¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024³â Á¦37Â÷ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ Çмú´ëȸ ¹× ÃÑȸ -1ÀÏÂ÷- : 2024-03-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024³â Á¦37Â÷ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ Çмú´ëȸ ¹× ÃÑȸ -1ÀÏÂ÷- : 2024-03-22
±³À°ÀÏÀÚ : 2024-03-22
±³À°Àå¼Ò : ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë, º¼·ë 1, 2

±³À°ÁÖÁ¦ : 2024³â Á¦37Â÷ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ Çмú´ëȸ ¹× ÃÑȸ -1ÀÏÂ÷-

ÁÖÃÖ±â°ü : ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ
´ã´çÀÚ : Á¤È¿°æ
¿¬¶ôó : 02-2279-9560  

À̸ÞÀÏ : kscvs@hanmail.net

±³À°Á¾·ù : ½Å°æ¿Ü°ú

Âü¼®¿¹»óÀÎ : 150¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 5 ½Ã°£ 50ºÐ

¼¼ºÎ¼ö°­·á : 90,000¿ø  

ºñ°í »çÀüµî·Ï ±âÁØ: Á¾½Åȸ¿ø 50,000¿ø / Á¤È¸¿ø 80,000¿ø / ºñȸ¿ø 90,000¿ø / ±ºÀÇ°ü,°øº¸ÀÇ 70,000¿ø / Àü°øÀÇ 50,000¿ø / °£È£»ç,¹æ»ç¼±»ç 30,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 08:30~08:45 Àü°øÀÇ Session I - Comparison between Endovascular Treatments in Intradural Vertebral Artery Dissecting Aneurysm : Flow Diverter, Multiple Stent Insertion, and Stent-Assisted Coil ÀåÇѳª(ÀÌÈ­¿©´ë ¸ñµ¿º´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 08:45~09:00 Àü°øÀÇ Session I - Case Report: Diagnosis and treatment of persistent primitive olfactory artery aneurysms ±æ¹Î±Ù(ÀÎÁ¦´ë ºÎ»ê¹éº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 09:00~09:15 Àü°øÀÇ Session I - Management combined hematoma of ruptured MCA aneurysm ±è±âÇö(±¤Áֱ⵶º´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 09:15~09:30 Àü°øÀÇ Session I - Effectiveness of Continuous Intra-arterial Nimodipine Infusion for the Treatment of Refractory Vasospasm after Aneurysmal Subarachnoid Hemorrhage ÀÌÇöºÀ(¼º±Õ°ü´ë °­ºÏ»ï¼ºº´¿ø ½Å°æ¿Ü°ú)

ÈÞ½Ä 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 09:30~09:50 Opening remark & Ãà»ç ¹ÚÀͼº ȸÀå ¿Ü 2¸í(´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ ȸÀå)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 09:50~10:00 Free paper I - Intracerebral Hemorrhage Caused by the Rupture of a Traumatic Pseudoaneurysm in the Middle Meningeal Artery : review ±è¸í¼ö(±¹¸³Áß¾ÓÀÇ·á¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 10:00~10:10 Free paper I - Incidence and Characteristics of Cerebral Infarction after Microsurgical Clipping of Unruptured Anterior-circulation Cerebral Aneurysms : Diffusion-weighted Imaging-based Analysis of 600 Patients ÇÑÇöÁø(¿¬¼¼´ë ¼¼ºê¶õ½ºº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 10:10~10:20 Free paper I - Hemodynamic simulation of aneurysms and major arteries after temporary strangulation of the common carotid artery during surgical clipping of middle cerebral bifurcation aneurysms ³²ÅñÕ(Á߾Ӵ뺴¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 10:20~10:30 Free paper I - Age-dependent characteristics and risk factors impacting clinical outcomes in aneurysmal subarachnoid hemorrhage ¹Ú»ó±Ô(¿¬¼¼´ë °­³²¼¼ºê¶õ½ºº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 10:30~10:40 Free paper I - Importance of careful analysis of preoperative study in patients with planned extracranial-intracranial bypass for large artery occlusion ±è´ë¿ø(¿ø±¤´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 10:40~10:50 Free paper I - Management of Recurrent Ischemic Stroke and Mycotic Aneurysm-Associated Subarachnoid Hemorrhage in Invasive Fungal Carotiditis: Two case reports À±º°Èñ(ÀÇÁ¤ºÎÀ»Áö´ëº´¿ø ½Å°æ¿Ü°ú)

ÈÞ½Ä 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 10:50~11:10 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 11:10~11:40 Special lecture - Management of aneurysmal subarachnoid hemorrhage by Clazosentan; review of clinical trials and early experience in Japan Miki Fujimura(Hokkaido University, Sapporo, Japan)

Åä·Ð 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 11:40~11:50 Åä·Ð ()

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 11:50~12:15 Á¤³â±â³ä Ưº°°­¿¬ - ³ª¿Í ³úÇ÷°ü ¼ö¼ú ¿Àâ¿Ï(ºÐ´ç¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

ÈÞ½Ä 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 12:15~12:30 ÈÞ½Ä ()

½Ä»ç 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 12:30~13:30 Luncheon seminar: Controversy in Cerebrovascular surgery I ()

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 13:30~13:40 Free paper II - Association of Bypass Surgery and Mortality in Moyamoya Disease À嵿±Ô(°¡Å縯´ë ÀÎõ¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 13:40~13:50 Free paper II - Analysis of Factors Affecting Good Neovascularization After Indirect Bypass Surgery: A Two-center Retrospective Study ±è»ó¿í(¸íÁö¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 13:50~14:00 Free paper II - Prediction of Contralateral Progression in Patients with Bilateral Nonhemorrhagic Moyamoya Disease following Unilateral Revascularization Surgery ¹æâȯ(Áß¾Ó´ë ±¤¸íº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 14:00~14:10 Free paper II - Sulcal hyperintense vessel (vessel wall MR ivy sign) in adult moyamoya disease: A high-resolution vessel wall imaging study À¯Áö¿í(°æÈñ´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 14:10~14:20 Free paper II - Long-term outcomes comparison between combined and indirect bypass surgery in adult moyamoya disease: an intra-individual study Á¤À¯È¯(¼­¿ï´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 14:20~14:30 Free paper II - Angiographic and Clinical Outcomes of Various Techniques of Intracranial-to-Intracranial Bypass for Complex Cases with a Review of Pertinent Literature and Illustrated Cases ±è¿õ¹ü(Àü³²´ëº´¿ø ½Å°æ¿Ü°ú)

ÈÞ½Ä 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 14:30~15:00 ¸í»çƯ°­ - °¡Ä¡ÀÖ´Â »î°ú ¾Æ¸§´Ù¿î ¸¶¹«¸® Á×À½ Á¤ÀÇÈ­ Àü ±¹È¸ÀÇÀå(ºÀ»ýº´¿ø)

ÈÞ½Ä 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 15:00~15:15 ÈÞ½Ä ()

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 15:15~15:35 Surgical clipping pros and cons ÁÖ¼ºÇÊ(Àü³²´ëº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 15:35~15:55 (Stent assisted) coiling pros and cons ±èÅ°ï(Â÷ÀÇ°úÇÐ´ë ºÐ´çÂ÷º´¿ø ½Å°æ¿Ü°ú)

Åä·Ð 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 15:55~16:00 Åä·Ð ()

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 16:00~16:10 Free paper III - Experience with Endovascular Treatment for Cerebral Vasospasm after Subarachnoid Hemorrhage: A Single Center Retrospective Review in Recent Two Years. ¾ç±¸Çö(¿ï»ê´ë °­¸ª¾Æ»êº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 16:10~16:20 Free paper III - Treatment outcomes of large and giant intracranial aneurysms according to various treatment modality ÃÖÀçÈ£(°¡Å縯´ë ¼­¿ï¼º¸ðº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 16:20~16:30 Free paper III - Development of computational prognostic prediction model and identifying featured prognostic factors using multicentered large cohort of patients diagnosed with aneurysmal subarachnoid hemorrhage ±èÀåÈÆ(°í·Á´ë ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 16:30~16:40 Free paper III - Long-term outcome followed for more than 5 years after revascularization surgery for the treatment of atherosclerotic steno-occlusive disease: poor outcome prediction using machine learning and analysis of the results ÃÖÁØÈ£(¿ï»ê´ë ¼­¿ï¾Æ»êº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 16:40~16:50 Free paper III - Clinical Significance of Prehospital Telecommunication Defined as the Critical Stroke Call Pathway in Acute Ischemic Stroke Requiring Intra-Arterial Recanalization Therapy Áø¼ºÃ¶(ÀÎÁ¦´ë ÇØ¿î´ë¹éº´¿ø ½Å°æ¿Ü°ú)

±³À°½Ã°£ 03¿ù 22ÀÏ ½Ã±×´Ï¿¤ ºÎ»ê 4Ãþ ±×·£µåº¼·ë 16:50~17:00 Free paper III - A comparative study of patients who underwent EC-IC bypass after failed intra-arterial thrombectomy with those who did not Á¶ÇöÁØ(°í·Á´ë ±¸·Îº´¿ø ½Å°æ¿Ü°ú)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024³â Á¦37Â÷ ´ëÇѳúÇ÷°ü¿Ü°úÇÐȸ Çмú´ëȸ ¹× ÃÑȸ -1ÀÏÂ÷- : 2024-03-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑôÃ߽Űæ¿Ü°úÇÐȸ ´ëÀüÃæûÁöȸ Á¦17Â÷ Á¤±âÇмú´ëȸ : 2024-03-22
´ÙÀ½±Û ´ëÇÑ»êºÎÀΰúÇÐȸ ºÎ»êÁöȸ 3¿ù Çмú¸ðÀÓ : 2024-03-21
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20500 ¼­¿ï 2024 Á¦2Â÷ ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸºÎÀοµ»ó¿¬±¸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-12 0 11 2024-04-29
20499 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2024-05-11 0 11 2024-04-29
20498 ºÎ»ê ¸¸¼ºÆó¼â °ü»óµ¿¸Æ ÁßÀç½Ã¼ú¿¬±¸È¸ The 23rd K-CTO(Korean Chronic Total Occlusion Club) Live Demonstration : 2024-05-11 0 28 2024-04-29
20497 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ The 3rd Korean Prostate Society Prostate Cancer Working Group Symposium : 2024-05-11 0 12 2024-04-29
20496 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11 0 18 2024-04-29
20495 ¼­¿ï Á¦77Â÷ ´ëÇÑû°¢ÇÐȸ Çмú´ëȸ : 2024-05-11 0 27 2024-04-29
20494 ÀÎõ Á¦9ȸ °¡Ãµ´ë ±æº´¿ø ½Å°æ¿Ü°ú ¾÷µ¥ÀÌÆ® ½ÉÆ÷Áö¿ò (G-NeUS) : 2024-05-11 0 12 2024-04-29
20493 ´ëÀü 2024³â ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Ãá°èÇмú´ëȸ & Basic Training Course : 2024-05-11 0 8 2024-04-29
20492 ±¤ÁÖ 2024³â ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Á¦37Â÷ Çмú´ëȸDAY2 : 2024-05-11 0 10 2024-04-29
20491 ¼­¿ï Á¦50ȸ ´ëÇÑÀÓ»óÇǺÎÄ¡·á¿¬±¸È¸ ±³À°½ÉÆ÷Áö¾ö : 2024-05-11 0 20 2024-04-29
20490 ¼­¿ï ÇѾç´ëÇб³º´¿ø Á¤Çü¿Ü°ú ⸳ 52Áֳ⠱â³äÇмú´ëȸ : 2024-05-11 0 43 2024-04-29
20489 ¼­¿ï °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ¼ºÇü¿Ü°úÇб³½Ç â¸³ 50Áֳ⠱â³ä Çмú´ëȸ : 2024-05-11 0 15 2024-04-29
20488 °æ±â ´ëÇѺÎÀÎÁ¾¾ç¿¬±¸È¸ KGOG 2024 Spring Semi-Annual Meeting (2ÀÏÂ÷) : 2024-05-11 0 18 2024-04-29
20487 °­¿ø 2024³â ´ëÇѺ´¸®ÇÐȸ º½Çмú´ëȸ(2ÀÏÂ÷) : 2024-05-10 0 15 2024-04-29
20486 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(1ÀÏÂ÷) : 2024-05-10 0 22 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷